—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Glaukos Corp (GKOS) — Technical state

As of 2026-11-10 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 50 out of 100 (momentum 93 · quality 29 · valuation 14), as of 2026-11-11.
  • Signal: Uptrend stack intact — Trades +30.8% vs the 50-day and +62.5% vs the 200-day average, 7.4% below the 52-week high and +181.9% off the 52-week low. Computed from daily closes. (as of 2026-11-10)
  • Trend: Glaukos Corp trades 30.8% above its 50-day and 62.5% above its 200-day moving average. (as of 2026-11-10)

Glaukos develops and sells devices and drug therapies for eye disease, with its core work centred on glaucoma. Its main products are the iStent and iStent infinite micro-bypass devices, which open natural drainage channels to relieve pressure inside the eye, alongside iDose TR, an implant that releases pressure-lowering medicine over time.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the GKOS overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Uptrend stack intact

Trades +30.8% vs the 50-day and +62.5% vs the 200-day average, 7.4% below the 52-week high and +181.9% off the 52-week low. Computed from daily closes.

Ranked #22 on today’s Directional Flow — Getting stronger list (scan of 2026-11-10).

The moving-average stack

Continue: the GKOS chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-10

Quick answers

What is the current Closelooknet signal on GKOS?

Uptrend stack intact — Trades +30.8% vs the 50-day and +62.5% vs the 200-day average, 7.4% below the 52-week high and +181.9% off the 52-week low. Computed from daily closes. As of 2026-11-10; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is GKOS above its 50-day and 200-day moving averages?

As of 2026-11-10, Glaukos Corp trades +30.8% above its 50-day and +62.5% above its 200-day average, with the 20-day +17.2% away.

How far is GKOS from its 52-week high?

7.4% below the 52-week high and 181.9% above the 52-week low, as of 2026-11-10.

Related in the Closelooknet universe

then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.